octagon
circle
img
$1M in savings and no impact on outcomes with appropriate Exparel utilization
$980k

annual savings in Exparel spend

85%

reduction in spend through appropriate usage

0

impact on outcomes

img
$1M savings in Ofirmev spend without impacting care quality
$1M+

annual savings in Ofirmev spend

54%

savings in parenteral anelgesics

0

impact on outcomes

img
Evidence saved health system $500K and controlled off-label use of IVIG
$480k

annual savings in IVIG spend

80%

IVIG volume standardized to one brand

50%

of top ten uses of IVIG impacted by guidelines